Evidence map›Paper›PMID 40890268›Full record

ArticleScientific reports2025

Geographical analysis of malignant tumor incidence and treatment in China.

Yudong Bian, Xunyi Yu, Jiang Zhang, Yongsheng Zhao, Ming Zheng, Chunzhen Tang, Xiaolei Zhang, Lili Yue

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yudong Bian *Liaoyang Petrochemical General Hospital, Liaoyang, 111000, China.
Xunyi Yu *Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, 110000, China.
Jiang Zhang *Key Laboratory of TCM Viscera Theory and Application of Ministry of Education, Liaoning University of Chinese Medicine, Shenyang, 110000, China.
Yongsheng ZhaoLiaoyang Petrochemical General Hospital, Liaoyang, 111000, China. 13998044361@163.com.
Ming ZhengLiaoyang Petrochemical General Hospital, Liaoyang, 111000, China.
Chunzhen TangLiaoyang Petrochemical General Hospital, Liaoyang, 111000, China.
Xiaolei ZhangLiaoyang Petrochemical General Hospital, Liaoyang, 111000, China.
Lili YueLiaoyang Petrochemical General Hospital, Liaoyang, 111000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Malignant tumors have a severe impact on both patients and their families, and the treatment of malignant tumors is a fundamental component of public health security. Therefore, the issue of malignant tumors is a significant focus in the construction of "Healthy China." There are notable spatial disparities in both the incidence and treatment of malignant tumors in China. Research from a geographical perspective and methodology can help improve local malignant tumor prevention efforts and optimize the national allocation of medical resources. This study collected case samples publicly disclosed by representative malignant tumor mutual assistance platforms in China. The analysis was conducted using prefecture-level regions as the basic unit, applying spatial correlation analysis, geographic detectors, multi-factor regression, geographic inequality decomposition, birth cohort analysis, and other methods. The key findings are as follows: (1) there is a strong spatial aggregation of six high-incidence malignant tumors: respiratory system, digestive system, breast system, reproductive system, urinary system, and endocrine system cancers; (2) natural and human geographical factors have significant explanatory power for the occurrence of malignant tumors, although the influencing factors vary widely among different types of tumors; (3) there are considerable disparities in the distribution of medical resources for malignant tumors across regions, and when patients choose to seek treatment in different locations, they take both geographical distance and the level of medical services into account; (4) the difference in the "treatment occurrence rate" of malignant tumors is substantial between the two sides of the "Hu Huanyong Line"; (5) the degree of inequality in the national "treatment occurrence rate" for malignant tumors is widening with the increasing number of patients born later, but is narrowing with the establishment of new hospitals. Finally, this paper proposes policy recommendations to improve the prevention, control, and treatment of malignant tumors based on local conditions.

Indexed as

NeoplasmsChinaFemaleGeographyHumansIncidenceMaleGeographic inequalityHealth geographyHealthy ChinaHospitalsInsuranceMalignant tumors

Identifiers

PMID40890268
PMCPMC12402056

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.